Agatharesinol tetraacetate

Details

Top
Internal ID 2340eb8c-eac0-4d24-8b7a-eefed61f37a2
Taxonomy Lignans, neolignans and related compounds
IUPAC Name [(E,2S,3S)-2-acetyloxy-3,5-bis(4-acetyloxyphenyl)pent-4-enyl] acetate
SMILES (Canonical) CC(=O)OCC(C(C=CC1=CC=C(C=C1)OC(=O)C)C2=CC=C(C=C2)OC(=O)C)OC(=O)C
SMILES (Isomeric) CC(=O)OC[C@H]([C@@H](/C=C/C1=CC=C(C=C1)OC(=O)C)C2=CC=C(C=C2)OC(=O)C)OC(=O)C
InChI InChI=1S/C25H26O8/c1-16(26)30-15-25(33-19(4)29)24(21-8-12-23(13-9-21)32-18(3)28)14-7-20-5-10-22(11-6-20)31-17(2)27/h5-14,24-25H,15H2,1-4H3/b14-7+/t24-,25+/m0/s1
InChI Key PJCBYROINUEMCX-PRANAVDNSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C25H26O8
Molecular Weight 454.50 g/mol
Exact Mass 454.16276778 g/mol
Topological Polar Surface Area (TPSA) 105.00 Ų
XlogP 3.60
Atomic LogP (AlogP) 3.83
H-Bond Acceptor 8
H-Bond Donor 0
Rotatable Bonds 9

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Agatharesinol tetraacetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9944 99.44%
Caco-2 - 0.5730 57.30%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.8788 87.88%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9210 92.10%
OATP1B3 inhibitior + 0.8701 87.01%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior + 0.9773 97.73%
P-glycoprotein inhibitior + 0.8601 86.01%
P-glycoprotein substrate - 0.8371 83.71%
CYP3A4 substrate - 0.5054 50.54%
CYP2C9 substrate - 0.7974 79.74%
CYP2D6 substrate - 0.8791 87.91%
CYP3A4 inhibition - 0.5457 54.57%
CYP2C9 inhibition - 0.5481 54.81%
CYP2C19 inhibition - 0.5491 54.91%
CYP2D6 inhibition - 0.9015 90.15%
CYP1A2 inhibition + 0.6045 60.45%
CYP2C8 inhibition - 0.8068 80.68%
CYP inhibitory promiscuity + 0.6337 63.37%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7257 72.57%
Carcinogenicity (trinary) Non-required 0.6334 63.34%
Eye corrosion - 0.9920 99.20%
Eye irritation - 0.9228 92.28%
Skin irritation - 0.8981 89.81%
Skin corrosion - 0.9913 99.13%
Ames mutagenesis - 0.6600 66.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8657 86.57%
Micronuclear - 0.6651 66.51%
Hepatotoxicity + 0.5500 55.00%
skin sensitisation - 0.7333 73.33%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity - 0.5778 57.78%
Mitochondrial toxicity - 0.9375 93.75%
Nephrotoxicity + 0.5806 58.06%
Acute Oral Toxicity (c) IV 0.5535 55.35%
Estrogen receptor binding + 0.8722 87.22%
Androgen receptor binding + 0.7664 76.64%
Thyroid receptor binding + 0.6578 65.78%
Glucocorticoid receptor binding + 0.8683 86.83%
Aromatase binding - 0.5381 53.81%
PPAR gamma + 0.5572 55.72%
Honey bee toxicity - 0.6714 67.14%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.6100 61.00%
Fish aquatic toxicity + 0.9952 99.52%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.28% 91.11%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 96.26% 96.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.14% 96.09%
CHEMBL2581 P07339 Cathepsin D 93.72% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.07% 95.56%
CHEMBL3060 Q9Y345 Glycine transporter 2 88.61% 99.17%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.24% 94.45%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.17% 86.33%
CHEMBL3401 O75469 Pregnane X receptor 86.02% 94.73%
CHEMBL221 P23219 Cyclooxygenase-1 80.99% 90.17%
CHEMBL4208 P20618 Proteasome component C5 80.09% 90.00%

Cross-Links

Top
PubChem 101932604
NPASS NPC62874
LOTUS LTS0264486
wikiData Q104403584